Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. To date, more than 200,000 patients worldwide have been treated using the company’s technologies and more than 550 systems have been installed in leading hospitals around the world. On November 4, 2008, the Company completed the acquisition of Chengdu Twin Peak Accelerator Technology Inc.
Accuray Incorporated (纳斯达克股票代码:ARAY)专业从事先进的放射治疗解决方案的开发和销售,其解决方案可用于治疗各种从最普通到最复杂的癌症。Accuray和北美、欧洲、中东以及亚太地区的医院和癌症治疗中心有着密切的合作关系。在2008年11月4日,宣布全资收购成都双峰加速器技术有限公司。
自从Accuray收购中国这家高科技民营企业后器,改变直线加速管供货来源单一的局面,而直线加速管又是公司生产的放疗设备Hi?Art的最重要的部件,同时,这项并购还能提高公司在支线加速器设计和制造上的竞争能力,有助于改善设备的稳定性,并有助于提升利润空间。
Welcome to visit our website www.accuray.com for more information.
请访问公司网站,了解更多信息。
应聘者请将中文(或英文)简历、身份证及学历证书复印件、近照、联系方式寄往公司。
公司网站:
联 系 人:人力资源